1590TiPSafety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
Reckamp, K L, Akerley, W, Calvo, E, Clarke, J, Edelman, M J, He, K, Moreno, V, Neal, J W, Owonikoko, T K, Patel, J D, Patel, S P, Riess, J W, Sacher, A G, Turcotte, S, Villaruz, L C, Zauderer, M G, FaVolume:
30
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.112
Date:
October, 2019
Fichier:
PDF, 89 KB
english, 2019
File converter
Plus de résultats de recherche
More benefits 
